198 related articles for article (PubMed ID: 29891493)
21. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
22. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ceccato F; Barbot M; Albiger N; Zilio M; De Toni P; Luisetto G; Zaninotto M; Greggio NA; Boscaro M; Scaroni C; Camozzi V
Eur J Endocrinol; 2016 Aug; 175(2):101-6. PubMed ID: 27185866
[TBL] [Abstract][Full Text] [Related]
23. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
[TBL] [Abstract][Full Text] [Related]
25. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
Ringe JD; Faber H; Fahramand P; Schacht E
J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
[TBL] [Abstract][Full Text] [Related]
26. Assessment of fracture risk.
Kanis JA; Borgstrom F; De Laet C; Johansson H; Johnell O; Jonsson B; Oden A; Zethraeus N; Pfleger B; Khaltaev N
Osteoporos Int; 2005 Jun; 16(6):581-9. PubMed ID: 15616758
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE
Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
[TBL] [Abstract][Full Text] [Related]
28. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
Nakamura Y; Suzuki T; Kato H
Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
[TBL] [Abstract][Full Text] [Related]
29. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
30. Osteoporosis and fractures in rheumatoid arthritis.
Wysham KD; Baker JF; Shoback DM
Curr Opin Rheumatol; 2021 May; 33(3):270-276. PubMed ID: 33651725
[TBL] [Abstract][Full Text] [Related]
31. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
Ann Intern Med; 1996 Dec; 125(12):961-8. PubMed ID: 8967706
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids.
Habib GS; Haj S
Clin Rheumatol; 2005 Apr; 24(2):129-33. PubMed ID: 15372317
[TBL] [Abstract][Full Text] [Related]
33. [Exploration of risk factors on the occurrence of osteoporotic vertebral fracture in patients with rheumatoid arthritis].
Liu W; Xu S; Ma X; Hu L; Peng L; Xu J
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):852-7. PubMed ID: 25586354
[TBL] [Abstract][Full Text] [Related]
34. Bone safety of low-dose glucocorticoids in rheumatic diseases.
Saag KG
Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
[TBL] [Abstract][Full Text] [Related]
35. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.
Masamoto K; Otsuki B; Fujibayashi S; Shima K; Ito H; Furu M; Hashimoto M; Tanaka M; Lyman S; Yoshitomi H; Tanida S; Mimori T; Matsuda S
Eur Spine J; 2018 Feb; 27(2):406-415. PubMed ID: 29185111
[TBL] [Abstract][Full Text] [Related]
37. [Bone mineral density in patients with rheumatoid arthritis].
Macovei L; Ancuţa C; Belibou C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):723-30. PubMed ID: 22046778
[TBL] [Abstract][Full Text] [Related]
38. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy.
Rentero ML; Amigo E; Chozas N; Fernández Prada M; Silva-Fernández L; Abad Hernandez MA; Rodriguez Barrera JM; del Pino-Montes J;
BMC Musculoskelet Disord; 2015 Oct; 16():300. PubMed ID: 26472426
[TBL] [Abstract][Full Text] [Related]
40. [Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis].
Nampei A; Hashimoto J
Clin Calcium; 2006 Nov; 16(11):1866-70. PubMed ID: 17079854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
